Trials / Completed
CompletedNCT02317744
Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will test the effectiveness of the combination of Naltrexone and Bupropion relative to placebo for reducing binge eating in persons with obesity and binge eating disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naltrexone and bupropion combination | |
| OTHER | Pill Placebo |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2014-12-16
- Last updated
- 2017-12-22
- Results posted
- 2017-12-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02317744. Inclusion in this directory is not an endorsement.